tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

APRE Stock Latest News

Aprea Therapeutics announces first patient dosed in ABOYA-119 Phase 1/2a trial
The FlyAprea Therapeutics announces first patient dosed in ABOYA-119 Phase 1/2a trial
8d ago
APRE
Aprea Therapeutics reports Q3 EPS (64c) vs (86c) last year
PremiumThe Fly
Aprea Therapeutics reports Q3 EPS (64c) vs (86c) last year
1M ago
APRE
Aprea Therapeutics Reports Promising Results for APR-1051 Trials
PremiumCompany Announcements
Aprea Therapeutics Reports Promising Results for APR-1051 Trials
2M ago
8K
APRE
Aprea Therapeutics presents preliminary results on APR-1051
PremiumThe Fly
Aprea Therapeutics presents preliminary results on APR-1051
2M ago
APRE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
WVE
APRE
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
APRE
DMAC
Aprea Therapeutics engages Philippe Pultar as senior medical advisor
Premium
The Fly
Aprea Therapeutics engages Philippe Pultar as senior medical advisor
2M ago
APRE
Aprea Therapeutics management to meet virtually with B. Riley
Premium
The Fly
Aprea Therapeutics management to meet virtually with B. Riley
4M ago
APRE
Aprea Therapeutics management to meet virtually with B. Riley
PremiumThe Fly
Aprea Therapeutics management to meet virtually with B. Riley
4M ago
APRE
Aprea Therapeutics sees cash runway into 4Q25
PremiumThe Fly
Aprea Therapeutics sees cash runway into 4Q25
4M ago
APRE
Aprea Therapeutics reports Q2 EPS (58c) vs. (87c) last year
PremiumThe Fly
Aprea Therapeutics reports Q2 EPS (58c) vs. (87c) last year
4M ago
APRE
Aprea Therapeutics announces first patient dosed in ACESOT-1051 Phase I trial
PremiumThe Fly
Aprea Therapeutics announces first patient dosed in ACESOT-1051 Phase I trial
6M ago
APRE
Aprea announces SRC enhances dosing of patients with ATRN-119 at 800 mg
PremiumThe FlyAprea announces SRC enhances dosing of patients with ATRN-119 at 800 mg
7M ago
APRE
Aprea Therapeutics reports Q1 EPS (67c) vs ($1.34) last year
Premium
The Fly
Aprea Therapeutics reports Q1 EPS (67c) vs ($1.34) last year
7M ago
APRE
APRE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
APRE Upcoming Earnings Report: What to Expect?
7M ago
APRE
Aprea Therapeutics appoints Mirza as Chief Medical Officer
PremiumThe Fly
Aprea Therapeutics appoints Mirza as Chief Medical Officer
8M ago
APRE
SLRX
Aprea Therapeutics files to sell 4.39M shares of common stock for holders
PremiumThe Fly
Aprea Therapeutics files to sell 4.39M shares of common stock for holders
9M ago
APRE
Aprea Therapeutics price target raised to $11 from $9 at Wedbush
PremiumThe Fly
Aprea Therapeutics price target raised to $11 from $9 at Wedbush
9M ago
APRE
Aprea Therapeutics sees cash runway into 3Q25
PremiumThe Fly
Aprea Therapeutics sees cash runway into 3Q25
9M ago
APRE
Aprea Therapeutics reports Q4 EPS (92c), consensus (77c)
PremiumThe FlyAprea Therapeutics reports Q4 EPS (92c), consensus (77c)
9M ago
APRE
APRE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
APRE Upcoming Earnings Report: What to Expect?
9M ago
APRE
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
ACAD
APRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >